BioCentury
ARTICLE | Company News

Axxam, Acousia deal

January 6, 2017 10:03 PM UTC

Axxam transferred undisclosed assets to Acousia's R&D programs. Acousia is developing small molecules to treat sensorineural hearing loss and to prevent hearing loss in at-risk patients. Last month, A...